Annals of Translational Medicine 2020-Jun
The recent failure of the PROMESA clinical trial for multiple system atrophy raises the question-are polyphenols a viable therapeutic option against proteinopathies?
Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard